There is no pinned content in this Editor's Picks module.
Click here to learn more about content pinning.
VP of Danaher, which owns Leica Microsystems Group. Gentronix has expanded its sales teams in the US and Europe, naming Dorothy Zelent to be director of North American operations and Simon Johns as European sales director. Zelent formerly was a senior...
PINC Research has maintained `Sell` on Glaxo SmithKline Pharmaceuticals (GSK) with a price target of Rs 1,880 as against the current market price (CMP) of Rs 2,088 in its report dated Feb. 16, 2012. The broking house gave the following rationale:...
A left-wing activist throws a bottle past the gates of British drugmaker GlaxoSmithKline Laboratories in Buenos Aires February 16, 2012. Long-standing diplomatic tensions over the Falkland islands have bubbled up in recent months in the run-up to the... View Photo »
world's largest research-ba... The world of electronic medical records is very secretive. Vendors will not allow their programs or data structures to be examined, even... We have posted multiple times about Avandia (rosiglitazone), GlaxoSmithKline's star-crossed glucose-lowering drug. While Avandia has ...
Incidence in Europe and the Americas is approximately 0.2 - 14 cases per 100,000 population and 0.3 - 4 cases per 100,000 respectively1. GlaxoSmithKline – one of the world’s leading research-based pharmaceutical and healthcare companies – is committed...
(NYSE: GSK) reports that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending marketing authorization for Nimenrix (MenACWY-TT) for active immunisation against invasive...
Amgen is a California-based company that researches, develops, makes and markets human therapeutics, both by itself and through joint ventures with companies like Pfizer Inc, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited and more. ...
A left-wing activist sets fire on a British flag during a demonstration outside British drugmaker GlaxoSmithKline Laboratories in Buenos Aires February 16, 2012. Long-standing diplomatic tensions over the Falkland islands have bubbled up in recent... View Photo »
We are grateful to Pfizer for their funding and their innovation in issuing a ‘challenge’ for others to fund the research, which is outside of the ‘normal’ scope of most commercial support of CME. We are thrilled that Glaxo Smith Kline and Lilly & Co have provided the needed funds to complete the resear...
The move comes after Argentinean President Cristina Fernandez pushed for negotiations with the UK over the sovereignty of the Malvinas Islands. Chanting “English out of Malvinas, Yankees out of Latin America”, the Argentinean activists burnt the...
Between August 2009 to January 2011, four cases of severe liver injury were reported in patients using Xenical where the role of orlistat could not be excluded, according to the European Medicines Agency. Like us on Facebook There were nine reports of...
There are no results for this module. Edit this module to change the search term used to query Wikipedia
A left-wing activist sets fire on a British flag during a demonstration outside British drugmaker GlaxoSmithKline Laboratories in Buenos Aires February 16, 2012. Long-standing diplomatic tensions over the Falkland islands have bubbled up in recent months in the run-up to the 30th...
View Photo »Workers try to put out fire at the gates of British drugmaker GlaxoSmithKline Laboratories headquarters during a protest by left-wing demonstrators in Buenos Aires February 16, 2012. Long-standing diplomatic tensions over the Falkland islands have bubbled up in recent months in the...
View Photo »Microsoft founder Bill Gates (R) speaks at the "Uniting to Combat Neglected Tropical Diseases" conference as GlaxoSmithKline Chief Executive Officer Andrew Witty looks on at the Royal College of Physicians in London January 30, 2012.
View Photo »Picture syringe on a vaccine production line taken on December 16, 2011 at the new plant of U.K.'s largest drug maker GlaxoSmithKline (GSK) in Saint-Amand-les-Eaux, northern France, one day after its inauguration.
View Photo »Picture of the new plant of U.K.'s largest drug maker GlaxoSmithKline (GSK) taken on December 16, 2011 in Saint-Amand-les-Eaux, northern France, one day after its inauguration.
View Photo »A man is at work at a vaccine production line, on December 16, 2011 at the new plant of U.K.'s largest drug maker GlaxoSmithKline (GSK) in Saint-Amand-les-Eaux, northern France, one day after its inauguration.
View Photo »In a file picture taken on July 13, 2011 News International Chairman and Chief Executive James Murdoch arrives for work in east London. James Murdoch, at the centre of the phone hacking scandal in his family's British newspaper business, has resigned from the board of GlaxoSmithKline,...
View Photo »The groundbreaking ceremony for the new GlaxoSmithKline (GSK) Building at Philadelphia's Navy Yard Corporate Center included a tree planting ceremony that underscored developers Liberty Property Trust and Synterra Partners as well as GSK's commitment to sustainability. Planting three...
View Photo »Scientist Joe Cohen is seen posing for a photograph at GlaxoSmithKline biologicals (GSK) research site in Rixensart, Belgium in this December 8, 2010 file photograph. For Joe Cohen, a GlaxoSmithKline research scientist who has spent 24 years trying to create the world's first malaria...
View Photo »BERLIN, GERMANY - OCTOBER 12: People walk past a building that houses offices of pharmaceutical giant GlaxoSmithKline, aluminum producer Trimet and Deutsche Boerse on Unter den Linden avenue in Mitte district on October 12, 2011 in Berlin, Germany. Mitte district is home not only to...
View Photo »Blood samples are pictured at the Swiss Laboratory for Doping Analysis in Epalinges near Lausanne in this July 15, 2008 file photo. The battle to keep drugs out of the London Olympics has started long before the opening ceremony next July. A sophisticated laboratory provided by...
View Photo »British Telecoms public telephone boxes are pictured in central London, on November 13, 2008. British telecoms operator BT Group said Thursday it will cut 10,000 jobs by March 2009 despite soaring profits, becoming the latest company to wield the axe as recession looms in Britain. ...
View Photo »Chief Business Officer of Dutch-based biotech Prosensa Luc Dochez speaks during an interview in Leiden February 10, 2011. Prosensa is one of a new wave of successful biotechs that are emerging, many of them in the Benelux and Scandinavia, and stepping over a past generation of biotech...
View Photo »CEO of Dutch-based biotech Prosensa, Hans Schikan talks during an interview in Leiden February 10, 2011. Prosensa is one of a new wave of successful biotechs that are emerging, many of them in the Benelux and Scandinavia, and stepping over a past generation of biotech casualties. The...
View Photo »Dutch-based biotech firm Prosensa's researchers work on developing, possibly the world's first treatment for Duchenne muscular dystrophy disease (DMD), at their new laboratory in Leiden February 17, 2011. Prosensa is one of a new wave of successful biotechs that are emerging, many of...
View Photo »A left-wing activist sets fire on a British flag during a demonstration outside British drugmaker GlaxoSmithKline Laboratories in Buenos Aires February 16, 2012. Long-standing diplomatic tensions over the Falkland islands have bubbled up in recent months in the run-up to the 30th...
View Photo »world's largest research-ba... The world of electronic medical records is very secretive. Vendors will not allow their programs or data structures to be examined, even... We have posted multiple times about Avandia (rosiglitazone), GlaxoSmithKline's star-crossed glucose-lowering drug. While Avandia has ...
We are grateful to Pfizer for their funding and their innovation in issuing a ‘challenge’ for others to fund the research, which is outside of the ‘normal’ scope of most commercial support of CME. We are thrilled that Glaxo Smith Kline and Lilly & Co have provided the needed funds to complete the resear...
He has been in large cap defensives such as GlaxoSmithKline and Imperial Tobacco since August, whereas the market is down 20pc
